Acthar Gel net sales of $170 million XIAFLEX net sales of $134 million Net sales from continuing operations of $468 million Loss from continuing operations of $114 million Adjusted EBITDA from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results